Alain Schreiber is Director & 10% at CADENCE PHARMACEUTICALS INC (CADX). They have made 14 open-market trades across 5 companies since 2007, most recently 2017-03-20.
CIK 0001225149
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
5 open-market purchases totalling $13.7M since 2008, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EGRX | SELL | 2017-03-16 | 2017-03-20 | $82.06 | $16.4M | -1.1% | +4.0% | -9.2% |
| EGRX | SELL | 2016-09-06 | 2016-09-08 | $62.43 | $8.1M | +5.7% | +9.5% | +24.0% |
| IMDZ | SELL | 2015-04-14 | 2015-04-16 | $28.23 | $1.5M | -45.2% | -0.3% | -0.3% |
| IMDZ | SELL | 2015-03-10 | 2015-03-12 | $24.94 | $3.2M | -45.2% | -0.3% | -0.3% |
| EGRX | BUY | 2014-02-18 | 2014-02-20 | $15.00 | $5.0M | -8.4% | -0.4% | -0.4% |
| AVNR | SELL | 2009-08-11 | 2009-08-13 | $3.58 | $3.2M | N/A | N/A | N/A |
| AVNR | BUY | 2008-09-08 | 2008-09-10 | $0.93 | $297K | N/A | N/A | N/A |
| AVNR | BUY | 2008-09-02 | 2008-09-04 | $0.93 | $357K | N/A | N/A | N/A |
| AVNR | BUY | 2008-08-27 | 2008-08-29 | $0.95 | $85K | N/A | N/A | N/A |
| OPTR | BUY | 2008-07-18 | 2008-07-22 | $8.48 | $8.0M | N/A | N/A | N/A |
| CADX | SELL | 2007-09-19 | 2007-09-19 | $13.90 | $1.0M | N/A | N/A | N/A |
| CADX | SELL | 2007-09-17 | 2007-09-19 | $14.07 | $519K | N/A | N/A | N/A |
| CADX | SELL | 2007-09-12 | 2007-09-14 | $13.56 | $41K | N/A | N/A | N/A |
| CADX | SELL | 2007-08-31 | 2007-09-04 | $14.47 | $830K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.